Role of nanotechnology in amplifying bioavailability

Abstract

Although nanotechnology and nanoscience methods for particle design and formulation are beginning to grow the market for many pharmaceuticals and are laying the groundwork for a lucrative niche within the business, some of the projected benefits have been exaggerated. This paper will discuss logical approaches to the nanoscale vehicle and entity design and surface engineering for site-specific drug delivery and medical imaging following parenteral administration. Nanomaterials help with targeted delivery, prolonged administration, and improved pharmacokinetics profiles, as well as medication diffusion into numerous organs by overcoming barriers such as the blood-brain barrier. Furthermore, these nanoparticles have a higher differential uptake efficiency in target cells (or tissue) compared to normal cells (or tissue) by preventing them from prematurely interacting with the biological environment, improving permeation and retention in disease tissues, and improving cellular uptake, resulting in lower toxicity. In this review, we discuss the most often utilized nanoparticles for increasing medication bioavailability.

This article is a part of Special Issue "Advances in the field of Nanomedicine"

References

1. Sahni JK, Baboota S, Ali J. (2011). Promising role of nanopharmaceuticals in drug delivery. Pharma Times. 43:16–18.
2. Patra, J.K., Das, G., Fraceto, L.F. et al. (2018). Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16, 7.1
3. Gunasekaran, Thirumurugan; Haile, Tedesse; Nigusse, Tedele; Dhanaraju, Magharla Dasaratha. (2014). Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pacific Journal of Tropical Biomedicine, 4, S1–S7.
4. Nawzat D. Al Jbour. (2022). Enhanced oral bioavailability through nanotechnology in Saudi Arabia: A meta-analysis. Arabian Journal of Chemistry, Volume 15(4), 103715,1878-5352.
5. Mian Kamran Sharif, Faiz-ul-Hassan Shah, Masood Sadiq Butt, Hafiz Rizwan Sharif. (2017). 15 - Role of nanotechnology in enhancing bioavailability and delivery of dietary factors. Nutrient Delivery, 587-618.
6. Rizwan Arshad, Lubaba Gulshad, Iahtisham-Ul- Haq, Muhammad Adil Farooq, Ammar Al-Farga, Rabia Siddique, Muhammad Faisal Manzoor, Emad Karrar. (2021) Nanotechnology: A novel tool to enhance the bioavailability of micronutrients. Food Sci Nutr.9:3354–3361.
7. S Moein Moghimi, A Christy Hunter, J Clifford Murray. (2005). Nanomedicine: current status and future prospects. Faseb J. 19(3):311-30, S Moein Moghimi, A Christy Hunter, J Clifford Murray. (2005). Nanomedicine: current status and future prospects. Faseb J. 19(3):311-30.
8. Patra, J.K., Das, G., Fraceto, L.F. et al. (2018). Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16, 71.
9. Brahmankar DM, Jaiswal SB. (1995). Biopharmaceutics and pharmacokinetics-A treatise. 1st ed. Delhi: Vallabh Prakashan Publishers. pp. 296–297.
10. Jia L, Zhao Y. Current evaluation of the millennium phytomedicine-ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. Curr Med Chem. 2009;16:2475–2484.
11. Jain, K. K. (2020). Role of nanobiotechnology in drug delivery. In K. Jain (Eds.), Drug delivery systems, methods in molecular biology. pp. 55- 73.
12. Serjay Sim, Nyet Kui Wong. (2021) Nanotechnology and its use in imaging and drug delivery (Review). Biomed Rep. 14(5): 42.
13. Yuanyuan Wang, Chao Pi, Xianhu Feng, Yi Hou, Ling Zhao, Yumeng Wei. (2020). The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs. International Journal of Nanomedicine 2020:15 6295–6310.
14. Maisel K, Ensign L, Reddy M, Cone R, Hanes J. (2015) Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release.197:48–57.
15. Li H, Chen M, Su Z, Sun M, Ping Q. (2016). Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Int J Pharm.511(1):524–537.
16. de la Fuente M, Csaba N, Garcia-Fuentes M, Alonso MJ. (2008). Nanoparticles as protein and gene carriers to mucosal surfaces. Nanomedicine (Lond).3(6):845–857.
17. Ensign LM, Tang BC, Wang YY, et al. (2012) Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med.4(138):138ra179.
18. Yuanyuan Wang, Chao Pi, Xianhu Feng, Yi Hou, Ling Zhao, Yumeng Wei. (2020) The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs. International Journal of Nanomedicine,15 6295–6310.
19. Maisel K, Ensign L, Reddy M, Cone R, Hanes J. (2015). Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release.197:48–57.
20. Li H, Chen M, Su Z, Sun M, Ping Q. (2016). Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Int J Pharm. 511(1):524–537.
21. de la Fuente M, Csaba N, Garcia-Fuentes M, Alonso MJ. (2008). Nanoparticles as protein and gene carriers to mucosal surfaces. Nanomedicine (Lond).3(6):845–857.
22. Ensign LM, Tang BC, Wang YY, et al. (2012). Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med. 4(138):138ra179.